• Quinn Supports ECI on their Latest Public to Private Investment

Quinn Supports ECI on their Latest Public to Private Investment

The Quinn Partnership advised ECI on their public to private - Ascribe Plc. Ascribe is a leading healthcare company that develops market software solutions that support patient, clinical and business processes to Primary and Secondary Health care providers in the UK and overseas.

Paul Quinn who led the Due Diligence commented, “We are especially pleased to have supported ECI on their second public to private investment, following on from their acquisition of Premier Research Group in June of last year.” Quinn added, “This is a highly experienced team with a successful track record. With the backing of ECI Partners, they are well positioned to take the business forward in a growing market, taking advantage of the opportunities which lie ahead.”

 

 

Copyright The Quinn Partnership